Project Details
Description
Randomized, double blind multicenter two stage adaptive Phase 3 study of intravenous administration of REOLYSIN in combination with Paclitaxel and Carboplatin vs the chemotherapy alone in patients with metastatic or recurrent squamous cell cacinoma
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/11 → 11/30/16 |
Funding
- Oncolytics Biotech Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.